L Prikler
PSA bounce after 125J-brachytherapy for prostate cancer as a favorable prognosticator
Engeler D, Schmid H, Plasswilm L, Schiefer J, Stucki P, Suter S, Prikler L, Hochreiter W, Thöni A, Schwab C, Putora P. PSA bounce after 125J-brachytherapy for prostate cancer as a favorable prognosticator. Strahlenther Onkol 2015; 191:787-91.
Jan 1, 2015PSA bounce after 125J-brachytherapy for prostate cancer as a favorable prognosticator
Jan 1, 2015Strahlenther Onkol 2015; 191:787-91
Engeler Daniel, Schmid Hans-Peter, Plasswilm Ludwig, Schiefer Johann, Stucki P, Suter S, Prikler L, Hochreiter W, Thöni A, Schwab Christoph, Putora Paul Martin
Therapie des lokalisierten Prostatakarzinoms. Brachytherapie mit permanenter, interstitieller Implantation von Jod-125
Schmid H, Prikler L. Therapie des lokalisierten Prostatakarzinoms. Brachytherapie mit permanenter, interstitieller Implantation von Jod-125. InFo Onkol Hämatol, 2: 2014:25-7.
Jan 1, 2014Therapie des lokalisierten Prostatakarzinoms. Brachytherapie mit permanenter, interstitieller Implantation von Jod-125
Jan 1, 2014InFo Onkol Hämatol, 2: 2014:25-7
Schmid Hans-Peter, Prikler L
[Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens]
Prikler L, Scandella E, Men Y, Engeler D, Diener P, Gillessen Sommer S, Ludewig B, Schmid H. [Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens]. Aktuelle Urologie 2004; 35:326-30.
Aug 1, 2004[Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens]
Aug 1, 2004Aktuelle Urologie 2004; 35:326-30
Prikler L, Scandella Elke, Men Y, Engeler Daniel, Diener P-A, Gillessen Sommer Silke, Ludewig Burkhard, Schmid H-P
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Dannull J, Diener P, Prikler L, Fürstenberger G, Cerny T, Schmid U, Ackermann D, Groettrup M. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. Cancer research 2000; 60:5522-8.
Oct 1, 2000Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Oct 1, 2000Cancer research 2000; 60:5522-8
Dannull J, Diener P A, Prikler L, Fürstenberger G, Cerny Thomas, Schmid U, Ackermann D K, Groettrup M